Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL5518 Target Snapshot

Misshapen-like kinase 1 · SINGLE PROTEIN · Homo sapiens

1,759Compounds
322Assays
19Approved Drugs
930.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q8N4C8. Use UniProt Q8N4C8 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q8N4C8 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Misshapen-like kinase 1 as ChEMBL target CHEMBL5518, mapped to UniProt Q8N4C8. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Misshapen-like kinase 1
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL5518
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q8N4C8
Misshapen-like kinase 1
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Misshapen-like kinase 1 is the right protein anchor across sources, using UniProt Q8N4C8 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelMisshapen-like kinase 1
UniProt AccessionQ8N4C8
Component TypeProtein
Sequence Length1332 aa

Misshapen-like kinase 1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Misshapen-like kinase 1, mapped to UniProt Q8N4C8. Sequence length is 1332 aa.

Mapped IDQ8N4C8
Review nameMisshapen-like kinase 1
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

19
Approved
11
Phase III
19
Phase II
9
Phase I
Assay Mix

Activity Type Distribution

IC5058.0
KI663.0
KD209.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL388978 9.63 IC50 0.235 Preclinical
CHEMBL388978 9.0 Kd 1.0 Preclinical
CHEMBL379975 8.9 Ki 1.259 Preclinical
CHEMBL4746566 8.89 IC50 1.3 Preclinical
CHEMBL1986943 8.5 Ki 3.162 Preclinical
CHEMBL288441 8.49 Kd 3.2 Approved
CHEMBL603469 8.44 Kd 3.6 Clinical
CHEMBL1991674 8.4 Ki 3.981 Preclinical
CHEMBL1998159 8.4 Ki 3.981 Preclinical
CHEMBL1996980 8.3 Ki 5.012 Preclinical
Distribution

pChEMBL Value Distribution

90
5.0
118
5.5
74
6.0
65
6.5
39
7.0
29
7.5
20
8.0
4
8.5
5
9.0
1
9.5
pChEMBL
Approved Drugs

Approved Drugs

NERATINIB
CHEMBL180022
Approved 2017
MIDOSTAURIN
CHEMBL608533
Approved 2017
NINTEDANIB
CHEMBL502835
Approved 2014
BOSUTINIB
CHEMBL288441
Approved 2012
AXITINIB
CHEMBL1289926
Approved 2012
SUNITINIB
CHEMBL535
Approved 2006
DASATINIB
CHEMBL5416410
Approved 2006
Assay Landscape

Assay Landscape

322
Total Assays
344
Tested Compounds
3
Assay Types
Binding — 320 assays, 82 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 252 53 6.8
assay format 29 6 6.7
cell-based format 29 12 6.3
subcellular format 10 11 6.7
Functional — 1 assays, 344 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 344 6.1
Toxicity — 1 assays, 1 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 1 6.1

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine